-+ 0.00%
-+ 0.00%
-+ 0.00%

*Bicara Therapeutics: $490M in Cash and Cash Equivalents Expected to Fund Ops Into the 1H of 2029 >BCAX

Dow Jones·03/27/2025 11:31:00

Please log in to view news